High-sensitivity CRP: an important prognostic marker in Acute Myocardial Infarction
Abstract
No abstract
References
1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105:1135-43.
2. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation. 2003; 107:499-511.
3. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000; 343:1139-47.
4. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004; 291:2727-33.
5. Parvez A, Srinivasa MD, Murthy1, Zafar L, Khan HS, Zaheer MS, Khan SA. Study of C-Reactive Proteins (hs- CRP) in patients of acute Myocardial Infarction. The Indian Practitioner. 2014(67.11)681-686.
6. Makrygiannis SS, Demail M, Ampartzidou OS, Zairis MN, Patsourakos NG, Pitsavos C, Tousoulis D, Prekates AA, Foussas SG, Cokkinos DV. Prognostic Usefulness of Serial C-Reactive Protein Measurements in ST-Elevation Acute Myocardial Infarction. Am J Cardiology. 2013;111(1)26–30.
7. Lim S, Hwang BH, Kim HY, Chang K, Jeong MH, Seung KB. 10 mg/L of high-sensitivity C-reactive protein on admission is a powerful predictive marker in patients with ST-segment
elevation myocardial infarction, but not in patients with non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64(11_S).
8. Lazaros G, Tousoulis D, Siasos G, Oikonomou E, Maniatis K, Zaromitidou M, Kioufis S, Kokkou E, Papageorgiou N, Aggeli C, Chrysohoou C, Vavuranakis M, Zakynthinos G, Papavassiliou A, Stefanadis CI. C- Reactive Protein as a risk factor for future cardiovascular events in patients with stemi and normal or mildly impaired left ventricle systolic function. J Am Coll Cardiol.. 2013;61(10_S) 60188-6.
2. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation. 2003; 107:499-511.
3. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000; 343:1139-47.
4. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004; 291:2727-33.
5. Parvez A, Srinivasa MD, Murthy1, Zafar L, Khan HS, Zaheer MS, Khan SA. Study of C-Reactive Proteins (hs- CRP) in patients of acute Myocardial Infarction. The Indian Practitioner. 2014(67.11)681-686.
6. Makrygiannis SS, Demail M, Ampartzidou OS, Zairis MN, Patsourakos NG, Pitsavos C, Tousoulis D, Prekates AA, Foussas SG, Cokkinos DV. Prognostic Usefulness of Serial C-Reactive Protein Measurements in ST-Elevation Acute Myocardial Infarction. Am J Cardiology. 2013;111(1)26–30.
7. Lim S, Hwang BH, Kim HY, Chang K, Jeong MH, Seung KB. 10 mg/L of high-sensitivity C-reactive protein on admission is a powerful predictive marker in patients with ST-segment
elevation myocardial infarction, but not in patients with non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64(11_S).
8. Lazaros G, Tousoulis D, Siasos G, Oikonomou E, Maniatis K, Zaromitidou M, Kioufis S, Kokkou E, Papageorgiou N, Aggeli C, Chrysohoou C, Vavuranakis M, Zakynthinos G, Papavassiliou A, Stefanadis CI. C- Reactive Protein as a risk factor for future cardiovascular events in patients with stemi and normal or mildly impaired left ventricle systolic function. J Am Coll Cardiol.. 2013;61(10_S) 60188-6.
Published
2019-09-05
How to Cite
Akshay Mehta. (2019). High-sensitivity CRP: an important prognostic marker in Acute Myocardial Infarction. The Indian Practitioner, 67(11), 657. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/718
Section
Editorial
